News

Published on 22 Sep 2024 on Benzinga · via Yahoo Finance

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor...

Article preview image

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

Monday, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) reported initial Phase 2 data of BDTX-1535.

The data demonstrated encouraging clinical responses and durability of BDTX-1535 in patients with relapsed/refractory epidermal growth factor receptor (EGFR)-mutant (EGFRm) non-small cell lung cancer (NSCLC).

Read the rest of the article
NASDAQ.BDTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor...

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type...

Benzinga · via Yahoo Finance 22 Sep 2024
Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy...

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of...

Key Insights Significantly high institutional ownership implies Black Diamond Therapeutics' stock...

Simply Wall St. via Yahoo Finance 22 May 2024
Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and Black Diam...

Zacks via Yahoo Finance 10 May 2024
With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional...

Key Insights Significantly high institutional ownership implies Black Diamond Therapeutics' stock...

Simply Wall St. via Yahoo Finance 5 Dec 2023
Black Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Update

<img src=https://s.yimg.com/ny/api/res/1.2/DdMmfHVZsMIU_n.1Gz3UTQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2M...

GuruFocus.com via Yahoo Finance 6 Nov 2023
Black Diamond Therapeutics Insider Ups Holding By 82% During Year

From what we can see, insiders were net buyers in Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX...

Simply Wall St. via Yahoo Finance 25 Oct 2023
Co-founder of cancer biotech Black Diamond replaced as CEO

The co-founder of a Cambridge biotech has been replaced as CEO. Black Diamond Therapeutics Inc....

American City Business Journals 18 Sep 2023
10 Healthcare Stocks with Insider Buying

In this article, we will take a look at the 10 healthcare stocks with insider buying. To see more...

Insider Monkey via Yahoo Finance 17 Aug 2023
Institutions profited after Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) market cap rose US$152m...

Key Insights Significant control over Black Diamond Therapeutics by private equity firms implies ...

Simply Wall St. via Yahoo Finance 28 Jun 2023

Copyright Statfolio @ 2024

Social Accounts